〔1〕 FORTINI A, FARAONE A, MEINI S, et al. Validity of “Sepsis-3” Criteria in Identifying Patients with Commu-nity-Onset Sepsis in Internal Medicine Wards; a Prospe-ctive, Multicenter Study〔J〕. Eur J Intern Med, 2021, 85: 92-97.
〔2〕 NI J, WANG H Y, LI Y, et al. Neutrophil to Lymphocyte Ratio (NLR) as a Prognostic Marker for In-Hospital Morta-lity of Patients with Sepsis: A Secondary Analysis Based on a Single-Center, Retrospective, Cohort Study〔J〕. Medicine, 2019, 98(46): e18029.〔3〕 HUANG Z, FU Z, HUANG W, et al. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Sepsis: A Meta-Analysis〔J〕. Am J Emerg Med,2020,38(3):641-647.
〔4〕 ZHANG K, ZHANG S, CUI W, et al. Development and Validation of a Sepsis Mortality Risk Score for Sepsis-3 Patients in Intensive Care Unit〔J〕. Front Med (Lausanne),2021,7:609769.
〔5〕 NG P Y, EIKERMANN M. The Obesity Conundrum in Sepsis〔J〕. BMC Anesthesiol, 2017, 17(1): 147.
〔6〕 CUI N, ZHANG H W, CHEN Z, et al. Prognostic Significance of PCT and CRP Evaluation for Adult ICU Patients with Sepsis and Septic Shock: Retrospective Analysis of 59 Cases〔J〕. J Int Med Res, 2019, 47(4): 1573-1579.
〔7〕 谢可心,李福兴,张玉琳,等.非侵入性生物标志物微小RNA在感染性疾病中的研究进展〔J〕.国际检验医学杂志,2021,42(3):365-370.
〔8〕 李福兴,王黎,樊玉娟,等.血清铁在脓毒症诊断及预后评估中的临床价值〔J〕.解放军医学杂志,2022,47(2):150-156.
〔9〕 ZHENG W F, ZHAN J, CHEN A, et al. Diagnostic Value of Neutrophil-Lymphocyte Ratio in Preeclampsia:A PRI-SMA-Compliant Systematic Review and Meta-Analysis〔J〕. Medicine (Baltimore),2019,98(51):e18496.
〔10〕 TORAMAN A, NEŞE N, ÖZYURT B C, et al. Asso-ciation between Neutrophil-Lymphocyte & Platelet Lym-phocyte Ratios with Prognosis & Mortality in Rapidly Progressive Glomerulonephritis〔J〕. Indian J Med Res,2019,150(4):399-406.
〔11〕 LIANG P, YU F. Value of CRP, PCT, and NLR in Prediction of Severity and Prognosis of Patients with Bloodstream Infections and Sepsis〔J〕. Front Surg,2022,9:857218.
〔12〕 KRIPLANI A, PANDIT S, CHAWLA A, et al. Neutro-phil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR) and Lymphocyte-Monocyte Ratio (LMR) in Predicting Systemic Inflammatory Response Syndrome (SIRS) and Sepsis after Percutaneous Nephrolithotomy (PNL)〔J〕. Urolithiasis, 2022, 50(3): 341-348.
〔13〕 DRĂGOESCU A N, PĂDUREANU V, STĂNCULESCU A D, et al. Neutrophil to Lymphocyte Ratio(NLR)-A Useful Tool for the Prognosis of Sepsis in the ICU〔J〕. Biomedicines,2021,10(1):75.
〔14〕 KILINC TOKER A, KOSE S, TURKEN M. Comparison of SOFA Score, SIRS, qSOFA, and qSOFA+L Criteria in the Diagnosis and Prognosis of Sepsis〔J〕. Eurasian J Med,2021,53(1):40-47.
〔15〕 LI Y L, YAN C J, GAN Z Y, et al. Prognostic Values of SOFA Score, qSOFA Score, and LODS Score for Patients with Sepsis〔J〕. Ann Palliat Med, 2020, 9(3): 1037-1044.
〔16〕 DYMICKA-PIEKARSKA V, WASILUK A. Procalcitonin (PCT), Contemporary Indicator of Infection and Inflam-mation〔J〕. Postepy Hig Med Dosw, 2015, 69: 723-728.
〔17〕 李福兴,和迎春,严萍,等.NLR在社区获得性肺炎病原诊断中的应用价值〔J〕.大理大学学报,2021,6(8):88-92.
〔18〕 ZHAI G H, ZHANG W, XIANG Z, et al. Diagnostic Value of SIL-2R, TNF-α and PCT for Sepsis Infection in Patients with Closed Abdominal Injury Complicated with Severe Multiple Abdominal Injuries〔J〕. Front Immu-nol, 2021, 12: 741268.
〔19〕 TAN M, LU Y, JIANG H, et al. The Diagnostic Accuracy of Procalcitonin and C-Reactive Protein for Sepsis: A Systematic Review and Meta-Analysis〔J〕. J Cell Biochem,2019,120(4):5852-5859.
〔20〕 MEISNER M. Update on Procalcitonin Measurements〔J〕. Ann Lab Med, 2014, 34(4): 263-273.
〔21〕 PAUDEL R, DOGRA P, MONTGOMERY-YATES A A, et al. Procalcitonin: A Promising Tool or Just Another Overhyped Test?〔J〕. Int J Med Sci,2020,17(3):332-337.
〔22〕 QU J, FENG P, LUO Y, et al. Impact of Hepatic Function on Serum Procalcitonin for the Diagnosis of Bacterial Infections in Patients with Chronic Liver Disease: A Retrospective Analysis of 324 Cases〔J〕. Medicine (Baltimore),2016,95(30):e4270.
〔23〕 LUAN Y Y, YAO Y M, XIAO X Z, et al. Insights into the Apoptotic Death of Immune Cells in Sepsis〔J〕. J Interferon Cytokine Res,2015,35(1):17-22.
|